⌘K
Loading ticker…
As of 2026-08-25, Tenax Therapeutics, Inc. (TENX) has a 3-month relative strength percentile of 2 within the TickerStance CS+ADRC universe (~5,000 tickers). Its Power rating (absolute 1–99) is 25. The current market Stance is 52.9 (Neutral). Sector: Healthcare, ranked 3 of 11. Average daily range 12.7%, relative volume 1.49×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.
TENX is in a stage 3 topping pattern, week 3. Extended from base. VCP detected: inconclusive. Distance from 50d / 200d: -79.8% / -80.8%.
Relative strength across horizons plus the leadership score.
Accumulation rating, relative volume, U/D ratio, breakout-day proof.
Diluted EPS, last 8 quarters. Loss makers are judged by progress toward breakeven.
TENX is held by 4 ETFs as of Apr 2026. Top owner: DFAS at 0.01% weight, $778K notional. Top 3 carry $988K.
Held by 7 ETFs · $5M across latest filings · largest weight 0.16% (TNXT).
Top 4 by value, from SEC N-PORT-P filings dated Apr 2026.
| ETF | Weight | Value | Δ |
|---|---|---|---|
| DFASDimensional U.S. Small Cap ETF | 0.01% | $778K | — |
| DFACDimensional U.S. Core Equity 2 ETF | 0.00% | $181K | new |
| DFAU | 0.00% | $30K | — |
| DCOR | 0.00% | $12K | — |
As filed in N-PORT — quarterly holdings with up to ~60-day publication lag. Not live positioning.
Weak relative strength and quiet attention. Little to read here either way.
Measures how unusual this name’s public attention is against its own 90-day history — a surprise reading, not a ranking of how watched it is versus other stocks. Intel, not a signal.
Daily range, ATR, beta, and the math for a 1-ADR stop.
YoY sales growth, last 8 quarters. Sales must back the earnings story.
Operating margin unavailable
YoY common shares outstanding. Down = buyback tailwind. Up > 2% = dilution flag.
Reported figures from SEC filings. No analyst estimates or forward guidance.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | TENX Jan avg: -11.43% median: -3.96% win: 25% σ: 19.60% n: 4 2022-04-12 → 2026-07-31 | TENX Feb avg: -34.36% median: -34.50% win: 0% σ: 37.08% n: 4 2022-04-12 → 2026-07-31 | TENX Mar avg: 0.93% median: 1.04% win: 50% σ: 27.41% n: 4 2022-04-12 → 2026-07-31 | TENX Apr avg: -15.10% median: -12.06% win: 0% σ: 9.67% n: 5 2022-04-12 → 2026-07-31 | TENX May avg: -2.52% median: -9.17% win: 40% σ: 10.54% n: 5 2022-04-12 → 2026-07-31 | TENX Jun avg: -13.38% median: -12.87% win: 20% σ: 27.73% n: 5 2022-04-12 → 2026-07-31 | TENX Jul avg: 1.67% median: 5.03% win: 60% σ: 10.27% n: 5 2022-04-12 → 2026-07-31 | TENX Aug avg: 3.72% median: 3.52% win: 50% σ: 12.57% n: 4 2022-04-12 → 2026-07-31 (current) | TENX Sep avg: -7.41% median: -13.91% win: 25% σ: 24.04% n: 4 2022-04-12 → 2026-07-31 | TENX Oct avg: -9.26% median: -12.98% win: 25% σ: 27.90% n: 4 2022-04-12 → 2026-07-31 | TENX Nov avg: 37.73% median: 25.29% win: 100% σ: 34.27% n: 4 2022-04-12 → 2026-07-31 | TENX Dec avg: -0.32% median: -2.92% win: 50% σ: 26.85% n: 4 2022-04-12 → 2026-07-31 |